Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Haufroid, V."" wg kryterium: Autor


Tytuł:
Unconjugated Hyperbilirubinemia in Acetaminophen-Related Acute Liver Failure.
Autorzy:
Philippart M; Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Mesland JB; Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Haufroid V; Louvain Centre for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Collienne C; Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Hantson P; Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Mar 22; Vol. 25, pp. e942703. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gilbert Disease*/diagnosis
Liver Failure, Acute*/chemically induced
Liver Failure, Acute*/diagnosis
Male ; Humans ; Middle Aged ; Acetaminophen/adverse effects ; Hyperbilirubinemia/chemically induced ; Hyperbilirubinemia/diagnosis ; Liver ; Bilirubin
Czasopismo naukowe
Tytuł:
Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury.
Autorzy:
André E; Department of Intensive Care, Cliniques Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium.
Lemaitre F; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, Environnement et travail)-UMR_S 1085, Rennes, France.; FHU SUPORT, Rennes F-35000, France.
Verdier MC; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, Environnement et travail)-UMR_S 1085, Rennes, France.; FHU SUPORT, Rennes F-35000, France.
Haufroid V; Clinical Chemistry Department, Cliniques universitaires Saint-Luc, 1200 Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, UCLouvain, 1200 Brussels, Belgium.
Pereira JP; Department of Intensive Care, Cliniques Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium.
Hantson P; Department of Intensive Care, Cliniques Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, UCLouvain, 1200 Brussels, Belgium.
Pokaż więcej
Źródło:
Case reports in critical care [Case Rep Crit Care] 2024 Feb 22; Vol. 2024, pp. 6631866. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Tytuł:
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response.
Autorzy:
Stillemans G; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Paquot A; Bioanalysis and Pharmacology of Bioactive Lipids, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
Muccioli GG; Bioanalysis and Pharmacology of Bioactive Lipids, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
Hoste E; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Panin N; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Åsberg A; Department of Pharmacology, School of Pharmacy, University of Oslo, Oslo, Norway.
Balligand JL; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Department of Internal Medicine, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Haufroid V; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Elens L; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2022 Mar; Vol. 15 (3), pp. 667-679. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Atorvastatin/pharmacokinetics ; Humans ; Liver-Specific Organic Anion Transporter 1/genetics ; Myalgia/chemically induced ; Myalgia/drug therapy ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell lines.
Autorzy:
Stillemans G; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Djokoto HP; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Delongie KA; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
El-Hamdaoui H; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
Panin N; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Haufroid V; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Elens L; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium. .; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 26; Vol. 11 (1), pp. 9000. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Darunavir*/pharmacokinetics
Darunavir*/pharmacology
Polymorphism, Genetic*
ATP Binding Cassette Transporter, Subfamily B/genetics ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; HEK293 Cells ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies